A meaningful DCF fair value isn't available for Hinge Health, Inc. (HNGE) — its free-cash-flow and net-debt profile makes a standard discounted-cash-flow model unreliable (common for loss-makers and high-net-debt or recently-public companies), and no analyst DCF is published. Explore your own assumptions with the editable model below.
Current Price
$97.67
Market-Implied Growth
N/A
Base-Case Model Value
N/A
Edit the assumptions to see how they change the estimated fair value. Opens seeded with TGM's data-driven base case for HNGE (growth from its own 5-year record, discount from its beta), so the sandbox starts where the scenarios above leave off. Illustrative model — not investment advice.
Base inputs: FCF $45.2M · 0.08B shares · net cash $208.0M
Estimated Fair Value
$10.67
-89.1% vs $97.67
How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 5.0%/yr FCF growth and 10-year horizon fixed. Green = above today's $97.67; red = below. Your current case is outlined.
| WACC ↓ / Terminal → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 8.8% | $12.07 | $12.62 | $13.24 | $13.98 | $14.85 |
| 9.8% | $10.92 | $11.32 | $11.78 | $12.30 | $12.91 |
| 10.8% | $10.01 | $10.32 | $10.67 | $11.05 | $11.50 |
| 11.8% | $9.28 | $9.53 | $9.79 | $10.09 | $10.42 |
| 12.8% | $8.68 | $8.88 | $9.09 | $9.33 | $9.58 |
